RxDoctor Payments Data

William Reiche

Internal Medicine · Omaha, NENPI 1679191050

Payments from drug & device makers

$2,262in general payments, 2019–2025

Across 104 payments — averaging $21.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$387
  • Johnson & Johnson$329
  • Takeda Pharmaceuticals U.S.A., Inc.$291
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$278
  • Boston Scientific$205
  • Sanofi$172
  • plus $600 from 11 others

What the payments were for

  • Food & beverage$2,262100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,262 in reported general payments places this provider in the 85th percentile of 570 internal medicine providers in Nebraska.

See all internal medicine providers in Nebraska

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine DrMesalamine12$5,180
Scopolamine12$1,706
Omeprazole31$553
Pantoprazole Sodium13$146

Paid to pharmacies, not to this prescriber.

Other internal medicine in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →